Carbapenam synthetase (hereafter named CPS) catalyzes the formation of the β-lactam ring in the biosynthetic pathway to (5R)-carbapen-2-em-3-carboxylate, the simplest of the carbapenem antibiotics. Kinetic studies showed remarkable tolerance to substrate stereochemistry on the turnover rate, but did not distinguish between chemistry and a non-chemical step such as product release or conformational change as rate-determining. Also, X-ray structural studies and modest sequence homology to β-lactam synthetase, an enzyme that catalyzes the formation of a monocyclic β-lactam ring in a similar ATP/Mg 2+ dependent reaction, implicate K443 as an essential residue for substrate binding and intermediate stabilization.In these experiments, we use pH-rate profiles, deuterium solvent isotope effects and solvent viscosity measurements to examine the rate-limiting step in this complex overall process of substrate adenylation and intramolecular ring formation. Mutagenesis and chemical rescue demonstrate that K443 is the general acid visible in the pH-rate profile of the wild-type CPS catalyzed reaction. On the basis of these results, we propose a mechanism where the rate-limiting step is β-lactam ring formation coupled to a protein conformational change, and underscore the role of K443 throughout the reaction.Resistance to antibiotics commonly used to combat infectious diseases is rising (1, 2). The β-lactam antibiotics, represented most prominently by penicillins and cephalosporins, constitute the largest portion of the world's antibiotic market despite inroads from resistant organisms (3). An important part of the continued successful use of penicillins and cephalosporins has been the introduction of clavulanic acid to overcome several widely encountered β-lactamases that confer resistance (4,5), and the advent of carbapenems that combine potent, broad-spectrum activity with reduced sensitivity to β-lactamases. These advances have extended the clinical usefulness of the β-lactam antibiotics now to more than 50 years, but the inexorable adaptation of disease-causing bacteria motivates continued efforts in semi-synthesis and pathway engineering (6) to yield new structures to counter evolving mechanisms of resistance.The centrally important β-lactam rings in clavulanic acid and the carbapenems are derived from β-amino acids by coupling their formation to the hydrolysis of ATP-a biosynthetic process wholly different from the oxidative cyclization reactions seen in penicillin and cephalosporin biosynthesis (7). β-Lactam synthetase (β-LS) closes N 2 -carboxyethyl-Larginine (CEA) to the monocyclic product, deoxyguanidinoproclavaminate (DGPC), enroute to clavulanic acid (8,9). In the (5R)-carbapen-2-em-3-carboxylate pathway, CPS, the distant homologue of β-LS (22% identity, 36% similarity) cyclizes (2S,5S)-5-carboxymethylproline * To whom correspondence should be addressed. Phone: (410) [(2S,5S)-CMPr] to (3S,5S)-carbapenam-3-carboxylate (10). While β-LS is specific for the Lconfigured substrate, CPS can cyclize (2S,5S)-CMPr...